NO831728L - Kinazolinforbindelser. - Google Patents

Kinazolinforbindelser.

Info

Publication number
NO831728L
NO831728L NO831728A NO831728A NO831728L NO 831728 L NO831728 L NO 831728L NO 831728 A NO831728 A NO 831728A NO 831728 A NO831728 A NO 831728A NO 831728 L NO831728 L NO 831728L
Authority
NO
Norway
Prior art keywords
formula
compound
salt
dioxide
alkyl
Prior art date
Application number
NO831728A
Other languages
English (en)
Norwegian (no)
Inventor
Simon Fraser Campbell
John K Stubbs
David A Roberts
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NO831728L publication Critical patent/NO831728L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO831728A 1982-05-15 1983-05-13 Kinazolinforbindelser. NO831728L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8214206 1982-05-15

Publications (1)

Publication Number Publication Date
NO831728L true NO831728L (no) 1983-11-16

Family

ID=10530384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831728A NO831728L (no) 1982-05-15 1983-05-13 Kinazolinforbindelser.

Country Status (22)

Country Link
US (1) US4489075A (forum.php)
EP (1) EP0094766B1 (forum.php)
JP (1) JPS58208289A (forum.php)
KR (1) KR840004747A (forum.php)
AU (1) AU538171B2 (forum.php)
CA (1) CA1195977A (forum.php)
DD (2) DD210269A5 (forum.php)
DE (1) DE3368631D1 (forum.php)
DK (1) DK210183A (forum.php)
ES (3) ES8407039A1 (forum.php)
FI (1) FI831684A7 (forum.php)
GR (1) GR77498B (forum.php)
IL (1) IL68668A0 (forum.php)
IN (1) IN160680B (forum.php)
NO (1) NO831728L (forum.php)
NZ (1) NZ204225A (forum.php)
PH (1) PH18763A (forum.php)
PL (2) PL241968A1 (forum.php)
PT (1) PT76687B (forum.php)
SU (1) SU1194257A3 (forum.php)
YU (1) YU105083A (forum.php)
ZA (1) ZA833422B (forum.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US5138062A (en) * 1989-10-03 1992-08-11 Philip Morris Incorporated Nicotine analogs
CZ289756B6 (cs) * 1991-03-28 2002-04-17 Eisai Co., Ltd. Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů
PL3143019T3 (pl) * 2014-05-15 2021-03-22 Pfizer Inc. Krystaliczna postać 6-[(4R)-4-metylo-1,2-dioksydo-1,2,6-tiadiazynan-2-ylo]izochinolino-1-karbonitrylu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971783A (en) * 1973-03-07 1976-07-27 Pfizer Inc. 4-Aminoquinazoline derivatives as cardiac stimulants
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines

Also Published As

Publication number Publication date
ZA833422B (en) 1984-02-29
EP0094766A2 (en) 1983-11-23
DD210269A5 (de) 1984-06-06
US4489075A (en) 1984-12-18
YU105083A (en) 1986-02-28
ES522278A0 (es) 1984-08-16
AU538171B2 (en) 1984-08-02
PH18763A (en) 1985-09-20
PL247054A1 (en) 1985-03-26
ES528481A0 (es) 1985-05-01
IN160680B (forum.php) 1987-07-25
EP0094766B1 (en) 1986-12-30
SU1194257A3 (ru) 1985-11-23
FI831684L (fi) 1983-11-16
ES8504793A1 (es) 1985-05-01
ES8407039A1 (es) 1984-08-16
GR77498B (forum.php) 1984-09-24
FI831684A0 (fi) 1983-05-13
IL68668A0 (en) 1983-09-30
DE3368631D1 (de) 1987-02-05
JPS58208289A (ja) 1983-12-03
KR840004747A (ko) 1984-10-24
DK210183A (da) 1983-11-16
FI831684A7 (fi) 1983-11-16
DD216018A5 (de) 1984-11-28
AU1452283A (en) 1983-11-17
PT76687A (en) 1983-06-01
ES528482A0 (es) 1985-05-01
PT76687B (en) 1986-03-27
PL241968A1 (en) 1984-08-13
NZ204225A (en) 1985-12-13
CA1195977A (en) 1985-10-29
EP0094766A3 (en) 1984-12-12
DK210183D0 (da) 1983-05-11
ES8504794A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
TWI229672B (en) Heterocyclic compounds as inhibitors of rotamase enzymes
US4806536A (en) Piperazinyl-substituted pyridine and imidazole anti-arrhythmic agents
US20070027118A1 (en) Novel compounds of amino sulfonyl derivatives
CA2315117C (en) Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
CA2292883A1 (en) Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
JP2002515008A (ja) ムスカリン・アンタゴニスト
IL118279A (en) Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
AU2011282887A1 (en) Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms
US4670449A (en) Dihydropyridines
CA2294549A1 (en) Heterocyclic substituted piperidines and uses thereof
DE19512639A1 (de) Benzonitrile und -fluoride
EP1243268A1 (en) Medicinal composition
CZ364698A3 (cs) 2,4-diaminopyrimidinové deriváty
US5364869A (en) Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
DE69736950T2 (de) Tricyclische piperdinyl derivate verwendbar als farnesyl-protein transferase inhibitoren
US4542132A (en) Cardiac stimulating cyclic sulfonamido substituted 4-piperidino-quinazoline derivatives, compositions, and method of use therefor
JPH05239026A (ja) メタノアントラセン化合物、これを含有する神経精神障害を治療するための調剤学的組成物、およびこの化合物を製造するための方法および中間体
NO171366B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(3-alkyloksy-4-piperidinyl)benzamider
US5037824A (en) N-containing heterocyclic compounds, compositions and use
NO831728L (no) Kinazolinforbindelser.
IL273748A (en) Troueryl compounds as positive allosteric modulators for muscarinic m1 receptors
US4783467A (en) Tetrahydroimidazoquinazolinone inotropic agents
KR20030066745A (ko) 펩타이드 화합물
US4990507A (en) N-containing heterocyclic compounds, and composition comprising the same
NO318938B1 (no) Benzo[5,6]syklohepta[1,2-b]pyridinderivater samt anvendelse derav for fremstilling av et medikament for inhibering av farnesylproteintransferase ved unormal cellevekst, og farmasoytisk preparat derav